ImmuPharma "absolutely delighted" to push on with new clinical trial -Tim McCarthy, FCCA, MBA - Chief Executive Officer, ImmuPharma 00:00:00
Tim has 40 years’ international senior level business experience in high growth biotech, healthcare and technology companies. He is also Chairman of Incanthera plc and 4basebio plc. Tim was formerly CEO and CFO of a number of UK public listed and private companies including, including Alizyme plc and Peptide Therapeutics Group plc, and has a core understanding of AIM and its regulatory processes.